DISSECTION P2381 - ESOC25-1554 OPTIMIZING PATIENT SELECTION FOR FIRST-LINE RITUXIMAB THERAPY IN PRIMARY ANGIITIS OF THE CENTRAL NERVOUS SYSTEM Jaroslava Paulasova Schwabova 1 , Katerina Benesova 1 , Tereza Ruzickova 1 , Silvia Kmetonyova 1 , Martin Elisak 1 , Ivana Sarbochova 1 , Hana Magerova 1 , Anna Olserova 1 , Jansky Petr 1 , Ales Tomek 1 1 1Department of Neurology, Charles University, Second Faculty of Medicine and Motol University Hospital, Prague, Czech Republic Background and Aims: Primary angiitis of the central nervous system (PACNS) is a rare yet serious condition, often challenging to diagnose and treat
The semaglutide injection also delays stomach emptying and directly affects the areas of your brain that control hunger
Considering the potential relief that rest and wrist brace can offer, its essential not to overlook this treatment option
It is not FDA-approved as a combination